Journal of Pediatric Neurology 2016; 14(03): 119-121
DOI: 10.1055/s-0036-1584551
Case Report
Georg Thieme Verlag KG Stuttgart · New York

Reversal of Cerebral Atrophy in a 4-Year-Old African Immigrant with Infantile-Onset Cerebral Folate Deficiency

John McLaren
1   University of Vermont College of Medicine, Burlington, Vermont, United States
,
Sean Conus
2   Department of Radiology, Maine Medical Center, Portland, Maine, United States
,
Alexa Craig
3   Department of Neurology, Maine Medical Center, Portland, Maine, United States
› Author Affiliations
Further Information

Publication History

03 March 2016

16 May 2016

Publication Date:
15 June 2016 (online)

Abstract

The cerebral folate deficiency (CFD) syndromes are a rare group of neurodevelopmental disorders defined by low levels of cerebrospinal fluid 5-methyltetrahydrofolate in the context of normal serum folate. Infantile-onset CFD, a phenotype of the CFD syndromes, typically presents between 4 and 6 months of age and is amenable to treatment with folinic acid. To date, only 20 cases of this phenotype have been reported. Here, we present a patient diagnosed at 4 years with infantile-onset CFD who demonstrated dramatic clinical and radiological improvement after supplementation with high-dose oral folinic acid. To our knowledge, this is the first reported case of an African patient with this condition and the first to capture neuroimaging both before and after treatment. With this case report, we aim to provide radiologic evidence and further demographic diversity to support existing guidelines for simple vitamin supplementation in this rare but treatable condition.

 
  • References

  • 1 Ramaekers V, Sequeira JM, Quadros EV. Clinical recognition and aspects of the cerebral folate deficiency syndromes. Clin Chem Lab Med 2013; 51 (3) 497-511
  • 2 Hunter R, Barnes J, Oakeley HF, Matthews DM. Toxicity of folic acid given in pharmacological doses to healthy volunteers. Lancet 1970; 1 (7637) 61-63
  • 3 Frye RE, Sequeira JM, Quadros EV, James SJ, Rossignol DA. Cerebral folate receptor autoantibodies in autism spectrum disorder. Mol Psychiatry 2013; 18 (3) 369-381
  • 4 Ramaekers VT, Häusler M, Opladen T, Heimann G, Blau N. Psychomotor retardation, spastic paraplegia, cerebellar ataxia and dyskinesia associated with low 5-methyltetrahydrofolate in cerebrospinal fluid: a novel neurometabolic condition responding to folinic acid substitution. Neuropediatrics 2002; 33 (6) 301-308
  • 5 Ramaekers VT, Blau N. Cerebral folate deficiency. Dev Med Child Neurol 2004; 46 (12) 843-851
  • 6 Djukic A. Folate-responsive neurologic diseases. Pediatr Neurol 2007; 37 (6) 387-397